KADCYLA
KADCYLA
Approved
DIN Number
02473224
Drug Class
Human
Market Date
Oct 24, 2018
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02473224
AIG Number0154730003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FD03 TRASTUZUMAB EMTANSINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRASTUZUMAB EMTANSINEActive
Strength: 160 MG / VIAL
Monograph: TRASTUZUMAB EMTANSINE